AstraZeneca PLC Files June 2025 6-K Report
Ticker: AZN · Form: 6-K · Filed: Jun 2, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, sec-filing, routine-report
Related Tickers: AZN
TL;DR
AZN filed its June 6-K, standard foreign issuer update.
AI Summary
AstraZeneca PLC filed a Form 6-K on June 2, 2025, reporting for the month of June 2025. The filing indicates AstraZeneca is a foreign issuer and files annual reports under Form 20-F. The company's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Why It Matters
This filing provides routine updates for AstraZeneca PLC as a foreign issuer, ensuring compliance with SEC reporting requirements for investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not contain new material financial or operational information.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report
- 001-11960 (company) — SEC File Number
- 1 Francis Crick Avenue (company) — Business and Mail Address
- Cambridge Biomedical Campus (company) — Business and Mail Address
- CB2 0AA (company) — Business and Mail Address ZIP Code
- United Kingdom (company) — Location of principal executive offices
- Form 20-F (company) — Annual report form
- Form 6-K (company) — Report type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or the rules of any stock exchange on which it is listed.
What is AstraZeneca PLC's SEC file number?
AstraZeneca PLC's SEC file number is 001-11960.
Where are AstraZeneca PLC's principal executive offices located?
AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Does AstraZeneca PLC file its annual reports under Form 20-F or Form 40-F?
AstraZeneca PLC indicates it files its annual reports under cover of Form 20-F.
What period does this Form 6-K report cover?
This Form 6-K reports for the month of June 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding ASTRAZENECA PLC (AZN).